Optiray 350 741 mg/mL

Optiray 350 741 mg/mL is a radiopaque contrast agent used for imaging procedures. This injection, containing ioversol, aids in enhancing visibility during diagnostic imaging. Ideal for intra-arterial and intravenous use, it supports clear visualization in medical imaging.

Optiray 350 741 mg/mL is primarily used as a contrast medium to improve the visibility of internal structures during imaging procedures. It is commonly administered for diagnostic imaging, including angiography and computed tomography (CT) scans. This contrast agent helps healthcare professionals obtain clearer images, aiding in the detection and evaluation of various conditions.

When administered, Optiray 350 741 mg/mL may cause temporary sensations such as warmth or flushing. Some individuals might experience mild discomfort at the injection site. These effects are generally short-lived and subside quickly. Always consult a healthcare provider for personalized information.

Optiray 350 741 mg/mL should be used with caution in individuals with known allergies to contrast agents or iodine. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the injection.

Optiray 350 741 mg/mL may interact with certain medications, including those that affect kidney function. It is advisable to disclose all current medications to a healthcare provider before using this contrast agent. Additionally, interactions with other contrast agents or diagnostic substances should be considered.